International Regulatory Affairs Consultancy Services - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

International Regulatory Affairs Consultancy Services

Establishing product registration requires expert advice and careful planning.

PharmaConsult Global’s regulatory team will guide you through the legal and regulatory minefield and ensure a clear path to market.

The company will provide a wide range of support, including:

  • Advice on the importation of biological products, including assistance with logistics, product release and regulation
  • Regulatory support for pharmaceutical development services, including manufacturing, analytical chemistry, formulation development, microbiology, biotechnology and clinical research
  • Development, preparation and assembly of complete dossiers.
  • Preparation of responses to regulatory authorities, comment letters and assessment reports
  • Representation to regulatory agencies and meeting planning
  • Regulatory submission critique, including recommendations to help improve review of applications by regulatory authorities
  • Assistance in responding to compliance issues
  • Accurate labelling
  • Due diligence on product regulatory packages
  • Dossier submission to regulatory authorities

Practical advice and help

PharmaConsult can provide advice on product formulation, indications and dosage instructions. It will resolve issues around products with specific difficulties.

For novel forms of therapy, we’ll represent your company. We’ll meet with regulatory agencies to discuss key concerns and report back on the best course of action.

Helping to resolve regulatory questions

Regulatory consultants act as a linchpin between many groups of people, from drug development teams through to marketing and legal affairs, as well as external health authorities.

Document preparation

Work begins as soon as a new drug is discovered and continues long after the product reaches pharmacy shelves. Stringent testing requirements have to be met and include accurate and detailed information along with convincing analysis and results.

Before documentation is submitted, it’s down to regulatory affairs to ensure the right tests have been done at the right times, and with the correct interpretation of results.

Even when a licence to sell a new treatment has been granted, work doesn’t end there. It’s important to ensure a medicine’s packaging is accurate and informs patient about benefits and potential drawbacks.

We’ll manage the implementation of responsible labelling and packaging to ensure new treatments are effective, have minimal risks and quickly reach your market.

Good labelling can safeguard against drug misuse and prevent dangerous side effects. Accurate labelling can be as much a lifesaver as the drug itself.

Helping you with your electronic submissions

Many regulatory authorities will now only accept electronic-only submissions with electronic common technical document (eCTD) format. This applies to both new and existing submission types.

Paper and other non-eCTD formats will only be received as an exception PharmaConsult Global will assist you in preparing your own eCTD dossier by providing:

  • Regulatory support during pharmaceutical development, preparing common technical document (CTD) ready documentation, including clinical, non-clinical, labelling, and chemistry, manufacturing and controls (CMC)
  • Development, preparation, assembly and submission of complete CTDs and marketing authorisation applications (MAA) for registration in Europe and the US
  • Preparation of responses to regulatory authorities, comment letters and assessment reports

Regulatory due diligence

Regulatory due diligence can be undertaken for potential licensing opportunities. Not only can PharmaConsult identify gaps in old dossiers, but the company can arrange for and manage the additional studies to complete the dossier.

The company will prepare the following documents on behalf of its clients:

  • Briefing documents for pre- new drug application (NDA) or European Medicines Asgency (EMA) scientific meetings
  • Expert reports such as CTD pharmaceutical, preclinical or clinical overviews
  • Mutual recognition response documents

More About This Company